Skip to main content Accessibility help
  • Print publication year: 2012
  • Online publication date: July 2012

Chapter 119 - Use of psychotropics in people with epilepsy

from Section 7 - Psychiatric, social and legal aspects


Alper K, Schwartz KA, Kolts RL, Khan A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry 2007;62:345–54.
Farooq S, Sherin A. Interventions for psychotic symptoms concomitant with epilepsy. Cochrane Database Syst Rev. 2008;(4):CD006118.
Forsgren L, Beghi E, Oun A, Sillanpaa M. The epidemiology of epilepsy in Europe – a systematic review. Eur J Neurol 2005;12:245–53.
Gaitatzis A, Trimble MR, Sander JW. The psychiatric comorbidity of epilepsy. Acta Neurol Scand 2004; 10:207–20.
Montgomery SA. Antidepressants and seizures: emphasis on newer agents and clinical implications. Int J Clin Pract 2005;59:1435–40.
Pisani F, Oteri G, Costa C, Di Raimondo G, Di Perri R. Effects of psychotropic drugs on seizure threshold. Drug Safety 2002;25:91–110.
Spina E, Perucca E. Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs. Epilepsia 2002;45(Suppl 2):7–44.
Taylor D, Paton C, Kapur S (eds). Depression and psychosis in epilepsy. In The Maudsley Prescribing Guidelines, pp. 335–8. 10th edn. London: Informa Healthcare; 2009.